Nu-Med Plus, Inc. (NUMD)

0.0850 +0.0181 (+27.06%) At close: 03:51PM EDT

Nu-Med Plus, Inc.

640 Belle Terre Road
Building 2 E
Port Jefferson, NY 11777
United States
(631) 403-4337
https://www.nu-medplus.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. William Charles Hayde	President, CEO & Chairman of the Board	N/A	N/A	1960
Mr. Keith L. Merrell	CFO, Principal Accounting Officer, Treasurer, Secretary & Director	N/A	N/A	1946
Dr. Craig W. Morrison M.D.	Chair of the Medical Advisory Committee	N/A	N/A	1944

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications, as well as portable delivery system. It serves hospitals, health systems, and the medical community. The company was incorporated in 2011 and is based in Port Jefferson, New York.

Corporate governance

Nu-Med Plus, Inc.’s ISS governance QualityScore as of 1 May 2024 is 2. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 4; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.